Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Free Cash Flow (2016 - 2025)

IGC Pharma has reported Free Cash Flow over the past 16 years, most recently at -$2.1 million for Q3 2025.

  • Quarterly Free Cash Flow fell 106.73% to -$2.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$5.6 million through Sep 2025, down 12.27% year-over-year, with the annual reading at -$4.9 million for FY2025, 8.06% up from the prior year.
  • Free Cash Flow was -$2.1 million for Q3 2025 at IGC Pharma, down from -$1.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$541000.0 in Q1 2024 and troughed at -$2.6 million in Q1 2021.
  • The 5-year median for Free Cash Flow is -$1.7 million (2023), against an average of -$1.7 million.
  • Year-over-year, Free Cash Flow soared 64.45% in 2024 and then crashed 106.73% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$2.4 million in 2021, then increased by 8.94% to -$2.2 million in 2022, then grew by 25.78% to -$1.7 million in 2023, then increased by 18.79% to -$1.3 million in 2024, then tumbled by 57.66% to -$2.1 million in 2025.
  • Per Business Quant, the three most recent readings for IGC's Free Cash Flow are -$2.1 million (Q3 2025), -$1.4 million (Q2 2025), and -$748000.0 (Q1 2025).